The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study.

By A. Mcneill, W. Rosamond, C. Girman, S. Golden, M. Schmidt, H. East, Christie M. Ballantyne, G. Heiss. Diabetes Care, 2005

1,024 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health, Surgery

View Paper: https://www.semanticscholar.org/paper/b8e927dbd8a7474c749a3eba960c3085aafd0434

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. R. Eckel
2. G. Kaltsas
3. E. Kassi
4. Panagiota Pervanidou
5. George P. Chrousos
6. E. Ford
7. S. Grundy

In Public Health, Environmental and Occupational Health

1. E. Ford

In Surgery

1. R. Eckel
2. E. Ford

Citations in the corpus

• The metabolic syndrome: time for a critical appraisal (2005, neutral): “[34] found that only an elevated blood pressure and low HDL-cholesterol were significantly associated with CHD.”
• Metabolic syndrome: definitions and controversies (2011, background): “Several epidemiological studies have confirmed the increased risk of CVD in individuals with MetS, independently of the diagnostic criteria used [32-39].”
• The metabolic syndrome. (2008, background): “On the other hand, post hoc analysis of the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) showed that individuals with the MetS had increased risk for major coronary events irrespective of their FRS (374).”